[1]
D. Bunger, A. Rajani, L. Patel, and S. Sharma, “Real-world utilization and acceptance of biosimilar bevacizumab in metastatic colorectal cancer in India”, Int J Basic Clin Pharmacol, vol. 11, no. 6, pp. 564–567, Oct. 2022.